nick ede
Imugene Limited
Sydney, Australia
Review Editor
Cancer Immunity and Immunotherapy
Imugene Limited
Sydney, Australia
Review Editor
Cancer Immunity and Immunotherapy
Biocruces Bizkaia Health Research Institute
Barakaldo, Spain
Review Editor
Cancer Immunity and Immunotherapy
Julius Maximilian University of WĂĽrzburg
WĂĽrzburg, Germany
Review Editor
Cancer Immunity and Immunotherapy
Izmir Institute of Technology
Urla, TĂĽrkiye
Review Editor
Cancer Immunity and Immunotherapy
University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Review Editor
Cancer Immunity and Immunotherapy
Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick (NIH)
Frederick, United States
Review Editor
Cancer Immunity and Immunotherapy
Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Cancer Immunity and Immunotherapy
Institute of Oncology Research (IOR)
Bellinzona, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
Faculty of Health Sciences, Ben-Gurion University of the Negev
Beer Sheva, Israel
Review Editor
Cancer Immunity and Immunotherapy
Purdue University
West Lafayette, United States
Review Editor
Cancer Immunity and Immunotherapy
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Cancer Immunity and Immunotherapy
Faculty of Medicine, University Hospital Leipzig
Leipzig, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Wisconsin-Madison
Madison, United States
Review Editor
Cancer Immunity and Immunotherapy
University of Colorado
Denver, United States
Review Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy